Log in to save to my catalogue

Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cance...

Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cance...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2202194496

Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

About this item

Full title

Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2019-04, Vol.25 (4), p.641-655

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Non-alcoholic fatty liver disease ranges from steatosis to non-alcoholic steatohepatitis (NASH), potentially progressing to cirrhosis and hepatocellular carcinoma (HCC). Here, we show that platelet number, platelet activation and platelet aggregation are increased in NASH but not in steatosis or insulin resistance. Antiplatelet therapy (APT; aspiri...

Alternative Titles

Full title

Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2202194496

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2202194496

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-019-0379-5

How to access this item